
FundingHealthcare & Life Sciences
Biopeak raises $2.7M from Nikhil Kamath
By Abha Lohia · Editor ·
Biopeak: valuation and funding and every story →
seedBengaluruFounded 2024
- Biopeak is India's first longevity and health optimisation brand, offering multidisciplinary specialist-led programs
- It raised $2.7M (₹24.8 Cr) in a round led by existing investor Nikhil Kamath through NKSquared
- The funds will be used to expand diagnostics, AI capabilities, launch a new Bengaluru centre, and grow the team
What happened
- Biopeak raised $2.7M (₹24.8 Cr) in its latest funding round.
- The round was led by Nikhil Kamath through NKSquared, who is also an existing investor.
- The company plans to use the funds to expand presence and deepen capabilities across diagnostics, proprietary AI, research, and program development.
- It will launch a new flagship centre in Bengaluru.
- The team will be expanded across clinical, research, product, and operations roles.
- Biopeak will also strengthen its network of global advisors and institutional partners for protocol development and clinical governance.
Why it matters
- Longevity and precision healthcare are gaining focus globally and in India.
- Biopeak's approach is designed around Indian health profiles and disease patterns.
- It collaborates with IISc and Longevity India to contextualise healthspan data for South Asian genetics, environment, and lifestyle.
The business
- Biopeak is India's first longevity and health optimisation brand.
- It offers multidisciplinary specialist-led programs combining diagnostics, proprietary AI-driven insights, targeted clinical interventions, and sustained follow-up.
- The technology profiles 130+ biomarker blood panels, genetic/epigenetic profiling, gut/oral microbiome mapping, hormonal analysis, salivary cortisol rhythms, and whole-exome functional genomics, paired with MRI, CT, DXA, ECHO, and Carotid IMT imaging.
- Its primary customer base is young professionals and affluent individuals, particularly women.
- It has specialised modules for women covering health, skin and gut longevity, and advanced imaging for silent degeneration.
- The team includes doctors, nutritionists, physiologists, and mental health experts.
- Biopeak's proprietary system is the Longevity Hexacode, a six-layer system.
The founders
SS
Shiva Subramanian
Co-founderWho put in money
- Nikhil Kamath lead — Existing investor in Biopeak; invested through NKSquared.
In numbers
$2.7Mfunding raised · 2026
$1.4Mfunding raised (previous) · 2024
$3.5Mseed round total · 2024
What happens next
- Expand presence and deepen capabilities across diagnostics, proprietary AI, research, and program development.
- Launch a new flagship centre in Bengaluru.
- Expand team across clinical, research, product, and operations.
- Strengthen network of global advisors and institutional partners for protocol development and clinical governance.
Earlier rounds
- 2024-07 · seed · $3.5M · led by Accel's Prashanth Prakash
- 2024-08 · seed (tranche) · $1.4M · led by Nikhil Kamath
Up against
Temple (Deepinder Goyal)UltrahumanGabitNoiseFITTRSychedelic4baseCare
Words to know
- Longevity Hexacode
- Biopeak's proprietary six-layer system for health optimisation.
- biomarker blood panels
- Tests that measure specific biological markers in blood to assess health status.
- whole-exome functional genomics
- Analysis of the protein-coding parts of genes to understand genetic influences on health.
- Carotid IMT imaging
- Ultrasound measurement of the thickness of carotid artery walls to assess cardiovascular risk.
The numbers around it
Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →
Other articles talking about it
Terms in this story
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
- Inside round: An inside round is a funding round led and funded by a startup's existing investors, with no new outside investor setting the price. It happens when the company needs cash and its current backers are willing to put in more, often because no outsider offers a better deal.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Biopeak → · All startup news on 2 February 2026 →
Is this Biopeak? Get your “Featured on StopDown” badge →